Skip to main content

Day: April 1, 2024

MegaWatt Enters into Share Exchange Agreement to Acquire Labrador Mineral Resources Inc.

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Vancouver, British Columbia, April 01, 2024 (GLOBE NEWSWIRE) — MegaWatt Lithium and Battery Metals Corp. (CSE:MEGA) (FSE: WR20) (OTCQB: WALRF) (the “Company” or “MegaWatt“) announces, it has entered into a share exchange agreement dated effective April 1, 2024 (the “Share Exchange Agreement”) among the Company, Labrador Mineral Resources Inc. (“Labrador”), a private company existing under the laws of British Columbia, and the shareholders of Labrador (the “Shareholders”), pursuant to which, subject to regulatory approval, the Company will acquire all of the issued and outstanding shares of Labrador (the “Proposed Transaction”). Labrador purchased a 100% interest (subject only to a 1.5% NSR) in the Benedict Mountains...

Continue reading

CervoMed Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Updates

– Announced private placement of up to $149.4 million led by RA Capital Management with participation from Armistice Capital, Special Situations Funds and Soleus Capital; pro forma cash and cash equivalents from upfront proceeds expected to provide runway through the end of 2025 – CervoMed on track to complete enrollment in 2Q 2024 in its RewinD-LB Phase 2b clinical trial evaluating neflamapimod in patients with dementia with Lewy bodies (DLB); topline data expected in 4Q 2024 – Integrated summary of results from AscenD-LB Phase 2a trial published in peer-reviewed journal and presentations at a major scientific conference further inform on the potential of neflamapimod in DLB and probability of success in RewinD-LB – Appointed Joshua Boger, Ph.D., as Chair of the Board of Directors; Dr. Boger is the founder and...

Continue reading

Aemetis Implements Microsoft Dynamics(TM) ERP System to Support Current Operations and Expansion Projects

CUPERTINO, CA, April 01, 2024 (GLOBE NEWSWIRE) — via NewMediaWire — Aemetis, Inc. (NASDAQ: AMTX), a renewable natural gas and renewable fuels company focused on low and negative carbon intensity products, today announced the design, installation and implementation of the Microsoft DynamicsTM enterprise resource planning (ERP) system worldwide for all Aemetis operations in the U.S. and India to support current operations and expansion projects.  The tools and processes required to operate a global company, including manufacturing, supply chain, finance and accounting, are included in the Microsoft DynamicsTM ERP system. The Microsoft DynamicsTM ERP system is designed to manage medium to large corporations and was selected specifically to provide a world-class platform for the Aemetis Biogas dairy renewable natural gas business,...

Continue reading

X4 Pharmaceuticals to Participate in Upcoming April Investor Conferences

BOSTON, April 01, 2024 (GLOBE NEWSWIRE) — X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that management will be participating in the upcoming Needham 23rd Annual Healthcare Conference being held virtually from April 8-11, 2024, and the Piper Sandler Spring Biopharma Symposium being held in Boston from April 16-17, 2024. Needham 23rd Annual Healthcare Conference  Date: Monday, April 8, 2024  Time: 9:30 AM ET  Format: Corporate Presentation  Webcast Link   Piper Sandler Spring Biopharma Symposium  Date: Wednesday, April 17, 2024  Format: 1×1 Meetings   About X4 Pharmaceuticals X4 Pharmaceuticals is a late-stage clinical biopharmaceutical company driven to improve the lives of people with rare diseases...

Continue reading

Plateau Excavation Moving Corporate Office to Cobb County

Moving corporate office from Austell, of over 40 years at this location, to KennesawPlateau Excavation, the largest sitework contractor in the SoutheastHyundai SK Battery Jobsite – Won Georgia Deal of the Year in 2023. This job alone is bringing 3500 new jobs to Bartow County.Kennesaw, GA, April 01, 2024 (GLOBE NEWSWIRE) — Plateau Excavation, the largest sitework contractor in the Southeast, founded in 1983, is pleased to announce the relocation of its corporate headquarters from Austell, GA, to Kennesaw, GA.  Plateau Excavation began its journey with leased machines and small jobs, seizing opportunities amidst the banking industry crisis of the early 80s. Recognizing the rapid growth of the Atlanta area, founder Greg Rogers dove headfirst into excavation, starting with grading streets in budding subdivisions and...

Continue reading

Smith+Nephew introduces the RENASYS™ EDGE Negative Pressure Wound Therapy System – an exciting new option in home-based care for patients living with chronic wounds

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, is pleased to announce the launch of its RENASYS EDGE Negative Pressure Wound Therapy (NPWT) System in the US as a patient-centric option for treating chronic wounds. The system is lightweight and compact allowing it to be easily carried or worn,1 it features a discreet canister, and operates quietly so as not to draw attention or disturb the patients’ daily activities.1It is estimated that the annual financial burden of chronic wounds in the US is $33 billion,2 and affecting some 8.2 million people.*3 The RENASYS EDGE System is designed for patients suffering from these wounds and living at home. Chronic wounds, including ulcers, have a huge impact on a patient’s life beyond just the pain and discomfort, with 68% often becoming self-conscious of their wound and...

Continue reading

NewAmsterdam Pharma Announces the Appointment of Juliette Audet as Chief Business Officer

NAARDEN, the Netherlands and MIAMI, April 01, 2024 (GLOBE NEWSWIRE) — NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease (“CVD”) with elevated low-density lipoprotein cholesterol (“LDL-C”), for whom existing therapies are not sufficiently effective or well-tolerated, today announced the appointment of Juliette Audet as Chief Business Officer (“CBO”), and her simultaneous resignation from the Company’s Board of Directors, both effective April 1, 2024. “We are privileged to welcome Juliette to our management team as CBO,” said Michael Davidson, M.D., Chief Executive Officer of NewAmsterdam. “Juliette has been a trusted advisor to NewAmsterdam as an investor and member...

Continue reading

SLR Investment Corp. Schedules the Release of its Financial Results for the Quarter Ended March 31, 2024

NEW YORK, April 01, 2024 (GLOBE NEWSWIRE) — SLR Investment Corp. (the “Company”) (NASDAQ: SLRC) today announced that it will release its financial results for the quarter ended March 31, 2024 on Wednesday, May 8, 2024 after the close of the financial markets. The Company will host an earnings conference call and audio webcast at 10:00 a.m. (Eastern Time) on Thursday, May 9, 2024. All interested parties may participate in the conference call by dialing (800) 445-7795 approximately 5-10 minutes prior to the call, international callers should dial (785) 424-1789. Participants should reference SLR Investment Corp. and Conference ID: SLRC1Q24. A telephone replay will be available until May 23, 2024 and can be accessed by dialing (800) 925-9394. International callers should dial (402) 220-5386. This conference call will also be broadcast...

Continue reading

Esperion to Ring Nasdaq Opening Bell Today, April 1, 2024

ANN ARBOR, Mich., April 01, 2024 (GLOBE NEWSWIRE) — Esperion (Nasdaq: ESPR) today announced that Sheldon Koenig, President and CEO, will ring the Nasdaq Stock Market (Nasdaq) opening bell at 9:30 a.m. ET today, April 1, 2024, to commemorate the U.S. Food and Drug Administration’s (FDA) recent approval of broad new labels for Esperion’s products. “We are honored to ring the Nasdaq opening bell to celebrate a significant milestone for Esperion,” said Mr. Koenig. “This ceremony marks an opportunity to recognize the progress our team has made in achieving these broad new labels, which will significantly reduce previously existing prescribing limitations. I’m pleased to be joined today by other members of our talented team, who have shown unwavering commitment to Esperion throughout this process and helped to get us to where we are...

Continue reading

aTyr Pharma to Participate in April Investor Conferences

SAN DIEGO, April 01, 2024 (GLOBE NEWSWIRE) — aTyr Pharma, Inc. (Nasdaq: LIFE), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform, today announced that the company will participate in two upcoming investor conferences scheduled to take place in April 2024. Details of the conferences appear below: Conference: Evercore ISI Diamonds in the Rough Webinar DayDate: Thursday, April 4, 2024 Time: 10:30am EDTLocation: VirtualFormat: Corporate Presentation with Q&A Session Conference: Piper Sandler Spring Biopharma SymposiumDate: Wednesday, April 17, 2024Location: Everett, MAFormat: 1×1 Investor Meetings For more information on how to register, please contact your Evercore ISI or Piper Sandler representative. About aTyr aTyr is...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.